Ahngook to launch an anti-climacteric drug.

Published: 2005-08-19 06:56:00

Updated: 2005-08-19 06:56:00

Ahngook has launched "Plactive inj.", an anti-climacteric drug for the improvement of climacteric disorders, a human placenta preparation, the bulk of which was supplied by the company authorized by the Ministry of Environment and processed at the institute of BGMP certified in order to keep elim...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK